Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint.
Clinical trials often involve a variety of clinical and laboratory measures that are used as endpoints and sometimes two of these measures are combined in one endpoint. When the individual components of such a combined endpoint are 'time to event' measurements, the analysis is straightforward if each of the components is measured frequently and regularly over time. However, the analysis of the combined endpoint is more difficult when one component of the endpoint is right censored and the other is interval censored. This paper describes a statistic, based on a rank ordering of events for such a combined measure. The power of the test statistic is explored.
Moyé
L A
LA
University of Texas Health Science Center, Houston 77025.
Davis
B R
BR
Hawkins
C M
CM
D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D006801:Humans; D015233:Models, Statistical; D017063:Outcome Assessment, Health Care